ARCHIVES

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

Philadelphia Firm Wins CIDAC Award

August 24, 1984

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994